4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-072002
Chief Scientific Officer sold 5,353 shares at an average $14.31 ($76,617)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Scientific Officer | 2026-02-23 | Sale 10b5-1 | −1,752 | $13.99 | $24,510 | 180,225 | D |
| Michaelson Jennifer Chief Scientific Officer | 2026-02-24 | Sale 10b5-1 | −3,601 | $14.47 | $52,106 | 176,624 | D |
| Open-market sales · 5,353 sh · avg $14.31 · $76,617 | |||||||
Loading xslF345X05/ownership.xml…